Christopher D Alafi
CIK 1299430 · last filed 2021-05-28
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$2.42M
Companies
2
Total Filings
87
Lifetime Open-Market Net
$39.60M
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| Intra-Cellular Therapies, Inc. (ITCI) Delisted | Director | 850,548 | $131.87 | $112.16M | $32.97M | 55 | 2021-05-28 |
| STXS | Director | 1,313,441 | $1.84 | $2.42M | $6.64M | 32 | 2013-08-20 |
Recent Filings · Page 2 of 9
87 filingsForm 4 transactions across all companies, newest first.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2020-01-03 | Intra-Cellular Therapies, Inc. (ITCI) Delisted | Grant (A) | +422 | $14.5K | EDGAR |
| 2019-10-02 | Intra-Cellular Therapies, Inc. (ITCI) Delisted | Grant (A) | +1,941 | $14.5K | EDGAR |
| 2019-09-11 | Intra-Cellular Therapies, Inc. (ITCI) Delisted | Buy (P) | +485,000 | $4.97M | EDGAR |
| 2019-09-04 | Intra-Cellular Therapies, Inc. (ITCI) Delisted | Buy (P) | +125,000 | $1.07M | EDGAR |
| 2019-07-02 | Intra-Cellular Therapies, Inc. (ITCI) Delisted | Grant (A) | +1,117 | $14.5K | EDGAR |
| 2019-06-26 | Intra-Cellular Therapies, Inc. (ITCI) Delisted | Grant (A) | — | $0 | EDGAR |
| 2019-06-19 | Intra-Cellular Therapies, Inc. (ITCI) Delisted | Gift (G) | −400,000 | $0 | EDGAR |
| 2019-06-19 | Intra-Cellular Therapies, Inc. (ITCI) Delisted | Buy (P) | +10,000 | $155.5K | EDGAR |
| 2019-06-14 | Intra-Cellular Therapies, Inc. (ITCI) Delisted | Buy (P) | +170,000 | $1.99M | EDGAR |
| 2019-05-15 | Intra-Cellular Therapies, Inc. (ITCI) Delisted | Buy (P) | +100,000 | $1.26M | EDGAR |
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.